Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Artrya Limited ( (AU:AYA) ).
Artrya Limited announced the issuance of 6,798,498 fully paid ordinary shares as part of a share placement. This issuance was conducted without disclosure under the Corporations Act, and the company confirmed compliance with relevant regulatory provisions. The move is part of its ongoing efforts to enhance its market operations and strengthen its position in the medical technology industry.
More about Artrya Limited
Artrya Limited, based in Perth, Australia, is an applied artificial intelligence healthcare company founded in 2018 and listed on the Australian Securities Exchange in 2021. It focuses on improving the diagnosis of coronary heart disease through deep-learning algorithms aimed at predicting and preventing acute coronary events.
YTD Price Performance: 54.72%
Average Trading Volume: 159,603
Technical Sentiment Consensus Rating: Sell
Find detailed analytics on AYA stock on TipRanks’ Stock Analysis page.
